INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $215,000 | – | 22,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 3,028,354 | $30,526,000 | 0.37% |
| Engineers Gate Manager LP | 96,105 | $969,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,600 | $621,000 | 0.06% |
| GAM Holding AG | 83,940 | $846,000 | 0.03% |
| SHELL ASSET MANAGEMENT CO | 90,282 | $910,000 | 0.02% |
| SFMG, LLC | 11,994 | $107,000 | 0.02% |
| QS Investors, LLC | 159,133 | $1,604,000 | 0.02% |
| Winslow, Evans & Crocker, Inc. | 4,060 | $42,000 | 0.01% |
| PANAGORA ASSET MANAGEMENT INC | 285,646 | $2,879,000 | 0.01% |
| PEAK6 Investments LLC | 225,800 | $2,276,000 | 0.01% |